PK/PD of warfarin associated with genetic polymorphisms of VKORC1 and CYP2C9 in indonesian patients

PK/PD of warfarin associated with genetic polymorphisms of VKORC1 and CYP2C9 in indonesian patients

Bibliographic Details
Main Authors:	Taofik Rusdiana, Takuya Araki, Tomonori Nakamura, Anas Subarnas, Koujirou Yamamoto
Format:	Article
Language:	English
Published:	Archives of Global Professionals 2012-01-01
Series:	Archives of Pharmacy Practice
Online Access:	http://www.archivepp.com/article.asp?issn=2045-080X;year=2012;volume=3;issue=1;spage=74;epage=74;aulast=Rusdiana;type=0

Similar Items

Comparison of the vkor inhibitory activities by S- and R -warfarin
by: Masashi Kawano, et al.
Published: (2012-01-01)

Polymorphisms of VKORC1 and CYP2C9 are associated with warfarin sensitivity in Chinese population
by: Jia LQ, et al.
Published: (2017-03-01)

Contribution of VKORC1 and CYP2C9 polymorphisms in the interethnic variability of warfarin dose in Malaysian populations
by: Gan, G.G., et al.
Published: (2011)

Identification of CYP2C9 and VKORC1 polymorphisms in Iranian patients who are under warfarin therapy
by: Behzad Poopak, et al.
Published: (2016-02-01)

Evaluation of the VKORC 1 and CYP2C9 Gene Polymorphisms and Their Effects on the Emergency Complications in the Patients Using Warfarin
by: Oğuz Yardım, et al.
Published: (2017-06-01)

New insights into the role of VKORC1 polymorphisms for optimal warfarin dose selection in Caribbean Hispanic patients through an external validation of a population PK/PD model
by: Karine Rodríguez-Fernández, et al.
Published: (2024-01-01)

The Effect of CYP2C9 and VKORC1 Genetic Polymorphism on Warfarin Dose Requirements in a Sample of Iraqi Patients
by: Maha Ali Saleh, et al.
Published: (2021-03-01)

Association between genetic polymorphisms of CYP2C9 and VKORC1 and safety and efficacy of warfarin: Results of a 5 years audit
by: Mansij Biswas, et al.
Published: (2018-12-01)

VKORC1 and CYP2C9 Genotype Variations in Relation to Warfarin Dosing in Korean Stroke Patients
by: Sea Mi Park, et al.
Published: (2013-05-01)

Warfarin dose and INR related to genotypes of CYP2C9 and VKORC1 in patients with myocardial infarction
by: Seljeflot Ingebjørg, et al.
Published: (2008-06-01)

VKORC1 Haplotypes in patients treated with warfarin
by: Beshna, E, et al.
Published: (2010)

Pharmacogenetics of VKORC1 in warfarin resistant patients.
by: Ong, Jacqueline Kai Mei.
Published: (2010)

Polymorphisms of CYP2C9*2, CYP2C9*3 and VKORC1 genes related to time in therapeutic range in patients with atrial fibrillation using warfarin
by: Silveira MMBM, et al.
Published: (2019-08-01)

The effect of CYP2C9*2, CYP2C9*3, and VKORC1-1639 G>A polymorphism in patients under warfarin therapy in city of Kermanshah
by: Zohreh Hosseinkhani, et al.
Published: (2018-01-01)

Polymorphism of the CYP2C9 and VKORC1 genes: a comment
by: Rujittika Mungmunpuntipantip, et al.
Published: (2021-09-01)

Influence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta-analysis.
by: Andrea L Jorgensen, et al.
Published: (2012-01-01)

Determination of Pleiotropic Effect of Warfarin in VKORC1 and CYP2C9 Genotypes in Patients With Heart Valve Replacement
by: Huma Shafique, et al.
Published: (2022-06-01)

Methylation of CYP1A1 and VKORC1 promoter associated with stable dosage of warfarin in Chinese patients
by: Shiwei He, et al.
Published: (2021-06-01)

A child with Kawasaki disease and genetic warfarin sensitivity from CYP2C9 and VKORC1 gene variants
by: Myeongseob Lee, et al.
Published: (2020-12-01)

VKORC1 and Novel CYP2C9 Variation Predict Warfarin Response in Alaska Native and American Indian People
by: Lindsay M. Henderson, et al.
Published: (2019-05-01)

VKORC1 gene polymorphism (-1639G>A) in warfarin therapy patients of Pakistani population
by: Muhammad Bilal Ghafoor, et al.
Published: (2022-02-01)

Clinical relevance of VKORC1 (G-1639A and C1173T) and CYP2C9*3 among patients on warfarin
by: Teh, L. K., et al.
Published: (2011)

Lack of correlation between INR and warfarin dose: a role of pharmacogenotyping of CYP2C9*3 and VKORC1 for anticoagulation
by: Salleh, Mohd Zaki, et al.
Published: (2009)

A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose.
by: Fumihiko Takeuchi, et al.
Published: (2009-03-01)

A cardiovascular phenotype in warfarin-resistant Vkorc1 mutant rats☆
by: Michael H. Kohn, et al.
Published: (2008-11-01)

Effect of atypical antipsychotics on glucose and lipid metabolism
by: Madoka Fujimaki, et al.
Published: (2012-01-01)

Clinical application for determination of darunavir using very limited volume of plasma by high-performance liquid chromatography with fluorescence detection
by: Daisuke Nagano, et al.
Published: (2012-01-01)

Hyper-responsiveness to warfarin in a young patient with the VKORC1 -1639GA/CYP2C9*1*46 genotype: a case report
by: Weam Aldiban, et al.
Published: (2022-10-01)

Validation of UV-Vis spectrophotometry methode for analysis of apigenin in celery extract (Apium graveolens L.)
by: Asep Nurrahman Yulianto, et al.
Published: (2017-12-01)

Frequency of two VKORC1 gene variants and its correlation with warfarin maintenance dose
by: esmat khaleqsefat, et al.
Published: (2018-12-01)

Effect of milk thistle (silybum marianum) on glucose and lipid metabolism
by: Yukina Nakagome, et al.
Published: (2012-01-01)

Frequency distribution of polymorphisms of CYP2C19, CYP2C9, VKORC1 and SLCO1B1 genes in the Yakut population
by: Filipp Filippovich Vasilyev, et al.
Published: (2016-01-01)

Polymorphism of the CYP2C9 and VKORC1 genes in patients on the public health system of a municipality in Southern Brazil
by: Christiane Colet, et al.
Published: (2021-05-01)

<i>CYP2C9</i> Polymorphism Influence in PK/PD Model of Naproxen and 6-O-Desmethylnaproxen in Oral Fluid
by: Gabriela Moraes Oliveira, et al.
Published: (2022-11-01)

Phenprocoumon Dose Requirements, Dose Stability and Time in Therapeutic Range in Elderly Patients With CYP2C9 and VKORC1 Polymorphisms
by: Katharina Luise Schneider, et al.
Published: (2020-01-01)

Impact of VKORC1, CYP4F2 and NQO1 gene variants on warfarin dose requirement in Han Chinese patients with catheter ablation for atrial fibrillation
by: Jiao Li, et al.
Published: (2018-05-01)

Frequencies of VKORC1-1639G>A and rs397509427 in Patients on Warfarin and Healthy Syrian Subjects
by: Yara Altawil, et al.
Published: (2023-01-01)

VKORC1 pharmacogenetics and pharmacoproteomics in patients on warfarin anticoagulant therapy: transthyretin precursor as a potential biomarker.
by: Ramasamy Saminathan, et al.
Published: (2010-12-01)

<i>CYP4F2</i> and <i>VKORC1</i> Polymorphisms Amplify the Risk of Carotid Plaque Formation
by: Stefan Cristian Vesa, et al.
Published: (2020-07-01)

The prevalence of allelic variants of VKORC1, CYP2C9 and CYP4F2 genes in Zaporizhzhia region population
by: M. Yu. Kolesnik, et al.
Published: (2019-03-01)